Grove Biopharma, Inc. | $30,000,000 | (Apr 25, 2025)
Northwood | $30,000,000 | (Apr 25, 2025)
Steadily Insurance Company | $30,000,000 | (Apr 25, 2025)
Daymark Health
United States
- Philadelphia, PA
- 07/04/2025
- Seed
- $11,500,000
Daymark Health is a cancer care company that partners with health plans to provide in-home and virtual supportive and wraparound care to patients with cancer in collaboration with their own oncologists. Our mission is to transform the cancer care experience by delivering personalized, world-class care when and where patients need it most.
Our community-based team of nurses, nurse practitioners, social workers, and Health Partners works to address the clinical, mental health, and social needs, offering care navigation, 24/7 support, mental health assistance, symptom management, and social support – all delivered virtually and in the home.
- Industry Hospital & Health Care
- Website https://www.daymarkhealth.com/
- LinkedIn https://www.linkedin.com/company/daymarkhealth/
Related People
Justin BekelmanCo Founder
United States -
Philadelphia, Pennsylvania
Dr. Justin Bekelman is an internationally recognized oncologist and innovator who has devoted his career to improving the health and lives of patients with cancer. He is the co-founder and CEO of Daymark Health, a value-based oncology company redefining the cancer care experience for patients, providers, and health plans. Dr. Bekelman was inspired to start Daymark because he believes there is a better way to help patients access world-class, compassionate cancer care and to work with oncologists, health plans, and hospitals to change the system from within.
Throughout his 20-year career in oncology, Dr. Bekelman has made seminal discoveries that have changed the practice of cancer care. He has authored nearly 200 research articles and spearheaded large-scale research programs funded by the U.S. National Cancer Institute and the Patient Centered Outcomes Research Institute. Dr. Bekelman previously led Penn Medicine’s Center for Cancer Care Innovation at the Abramson Cancer Center and continues to see patients at the University of Pennsylvania School of Medicine. He also served as Special Assistant to the Under Secretary of Defense in the U.S. Department of Defense.
Alternative Payments | $22,000,000 | (Apr 25, 2025)
Listen Labs | $27,000,000 | (Apr 25, 2025)
Lace | $14,000,000 | (Apr 25, 2025)
RISE® Robotics | $1,500,000 | (Apr 25, 2025)
Ravenna | $15,000,000 | (Apr 25, 2025)
ChEmpower Corporation | $18,700,000 | (Apr 25, 2025)
Theo | $20,000,000 | (Apr 25, 2025)
Isembard | $9,000,000 | (Apr 25, 2025)
Electra(US) | $186,000,000 | (Apr 25, 2025)